• Press Release

Discovery’s Science Channel Partners With Mount Sinai Health System to Create Digital Series Featuring Innovations in Science and Medicine

  • New York, NY
  • (June 25, 2019)

Discovery’s Science Channel has teamed up with Mount Sinai Health System, one of the country’s leading academic medical institutions, to showcase some of the groundbreaking innovations in science and medicine that are transforming health care and providing new treatments for the most intractable diseases and conditions.

A series of six digital news segments will focus on the research and researchers at Mount Sinai who are working toward solutions to diagnose and cure everything from opioid addiction to spinal cord injuries, the brain injury seen in many former athletes and soldiers, and more.

The series will be shown at various times on Science Channel starting in June and will also be posted to Science Channel’s social media platforms.

The segments are:

A Digital Spinal Cord: 
THOMAS OXLEY, MD, PhD, a neurointerventionalist and a global expert in bionics, is helping paralyzed people turn their thoughts into actions. With funding from the U.S. Defense Department, he invented a microscopic device that when implanted in the brain transmits signals to seamlessly control an exoskeleton or artificial limbs and works as a digital spinal cord. The Department of Rehabilitation and Human Performance at Mount Sinai is one of the first in the nation to offer a robotic exoskeleton with powered leg attachments that enable paraplegics to stand upright, walk, and climb stairs.

Diagnosing Brain Injury Before It’s Too Late:
Chronic traumatic encephalopathy, or CTE for short, has been making headlines as more and more veterans and athletes are diagnosed postmortem with signs of CTE. SAM GANDY, MD, PhD, and his team are working to diagnose and treat it while people are still alive. They’re pioneering the use of a new imaging agent to detect and track progression of repetitive traumatic brain injury in patients with a history of concussions. The ability to see CTE in living patients is significant because it could help identify those who are beginning to experience brain damage and keep them off the playing field or battlefield, and open the door to potential treatments.

The Doctor’s Office of the Future:
Through a high-tech pop-up called Lab100, JOEL DUDLEY, PhD, and his team are building the hospital of the future. Working with a team in Silicon Valley and using the tools of data scientists and engineers, Dr. Dudley is revolutionizing patient care. By combining artificial intelligence, robotics, genomic sequencing, sensors, and wearable devices, he’s creating a completely individualized patient experience and using all of this data to reinvent the doctor’s office visit.

Reinventing Rehab for Spinal Cord Injuries:
After spending years working with Red Bull and Not Impossible Labs, DAVID PUTRINO, PhD, joined the Mount Sinai Performance Lab where people recovering from brain and spinal cord injuries can use their faces to control computers and video games. As Director of the Abilities Research Center at Mount Sinai, Dr. Purtrino and his team work to develop innovative technology solutions for individuals in need of better healthcare accessibility as well as those who want to perform better.

Using CBD to Cure Opioid Addiction:
With more than 115 Americans dying every day from opioid overdoses, there’s no question that the current tools in place to help addicts aren’t working. YASMIN HURD, PhD, and her team at Mount Sinai are changing that by investigating how using cannabinoids—chemicals extracted from the cannabis plant that, unlike the better-known THC, do not get you high—can reduce cravings and ease withdrawal symptoms in heroin users. By studying molecular and neurochemical reactions in the brain, Dr. Hurd has found that cannabinoids have long-lasting therapeutic effects for heroin addicts.

Depression? There’s an App for That:
Thanks to BRIAN IACOVIELLO, PhD, an Assistant Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and Head of Discovery and Translational Research for Click Therapeutics, and DENNIS CHARNEY, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs of the Mount Sinai Health System, the first “digital therapeutic” treatment for depression is about to hit the market. Using a phone or tablet, patients identify faces that display certain emotions. It seems like a game, but the app is using sophisticated systems to build a detailed understanding of each person’s brain structure. In a clinical study, those using the app had a significantly greater reduction of major depressive disorder symptoms compared to a control group. 

The series is produced for Science Channel and Mount Sinai by Bungalow Media + Entertainment. Executive Producers for Bungalow are Robert Friedman and Mike Powers.

About Science Channel:
Science Channel, a multi-media business unit of Discovery, Inc. is the home of all things science around the clock, including series such as MYTHBUSTERS, OUTRAGEOUS ACTS OF SCIENCE, WHAT ON EARTH?,  HOW THE UNIVERSE WORKS, UNEARTHED, and MYSTERIES OF THE ABANDONED. Science Channel’s programming also includes timely, expert-driven specials covering breaking science news and discoveries. Science Channel is the premiere TV, digital and social community for those with a passion for science, space, technology, archeology, and engineering, providing immersive, engaging, high-quality entertainment across all Science Channel assets including: Science Channel television network, available in more than 63 million homes in the U.S; complimentary Video On Demand offering; SCI Go app allowing viewers to catch up on full episodes of their favorite shows anytime; deep video, interactive storytelling and virtual reality at www.sciencechannel.com; and conversations on Science Channel’s popular social platforms including Facebook, Twitter, Instagram and Snapchat via @ScienceChannel.

About Discovery:
Discovery, Inc. (Nasdaq: DISCA, DISCB, DISCK) is a global leader in real life entertainment, serving a passionate audience of superfans around the world with content that inspires, informs and entertains. Discovery delivers over 8,000 hours of original programming each year and has category leadership across deeply loved content genres around the world. Available in 220 countries and territories and nearly 50 languages, Discovery is a platform innovator, reaching viewers on all screens, including TV Everywhere products such as the GO portfolio of apps; direct-to-consumer streaming services such as Eurosport Player and MotorTrend OnDemand; digital-first and social content from Group Nine Media and a strategic alliance with PGA TOUR to create the international home of golf. Discovery’s portfolio of premium brands includes Discovery Channel, HGTV, Food Network, TLC, Investigation Discovery, Travel Channel, MotorTrend, Animal Planet, and Science Channel, as well as OWN: Oprah Winfrey Network in the U.S., Discovery Kids in Latin America, and Eurosport, the leading provider of locally relevant, premium sports and Home of the Olympic Games across Europe. For more information, please visit https://corporate.discovery.com/ and follow @DiscoveryIncTV across social platforms.

ABOUT BUNGALOW MEDIA + ENTERTAINMENT, LLC:
Founded in 2013 by CEO Bob Friedman, a thirty-year veteran of the entertainment business having held senior roles at MTV, New Line Cinema, AOL and Radical Media, Bungalow is an integrated entertainment company that develops, produces and distributes content across all media platforms. Bob also serves on the Board of Mount Sinai.

Bungalow’s recently produced series include the Emmy Award winning GIVE for NBC, Corvette Heroes for the History Channel, The Panama Papers for EPIX, The Real SVU for Lifetime, Landmarks Live in Concert for PBS, Big Bad BBQ Brawl for the Cooking Channel, 36 Hours with the New York Times for the Travel Channel, the scripted dramas APB on Fox, Amazon’s Highston, Netflix’s Insatiable and feature documentaries Spring Broke on Showtime, We the People: The Market Basket Effect and the upcoming five-part mini-series The Preppie Murder for Sundance among others and various co-pros. Bungalow's feature film projects include Clive Owen’s The Confirmation.


About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in 4 out of 10 pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.